- Home
- POCI vs SLGL Comparison
POCI vs SLGL Comparison
Compare POCI & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POCI
- SLGL
- Stock Information
- Founded
- POCI 1982
- SLGL 1997
- Country
- POCI United States
- SLGL Israel
- Employees
- POCI N/A
- SLGL N/A
- Industry
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- POCI Health Care
- SLGL Health Care
- Exchange
- POCI Nasdaq
- SLGL Nasdaq
- Market Cap
- POCI 35.1M
- SLGL 19.3M
- IPO Year
- POCI N/A
- SLGL 2018
- Fundamental
- Price
- POCI $4.96
- SLGL $8.14
- Analyst Decision
- POCI
- SLGL Buy
- Analyst Count
- POCI 0
- SLGL 1
- Target Price
- POCI N/A
- SLGL $40.00
- AVG Volume (30 Days)
- POCI 17.1K
- SLGL 25.4K
- Earning Date
- POCI 05-15-2025
- SLGL 08-15-2025
- Dividend Yield
- POCI N/A
- SLGL N/A
- EPS Growth
- POCI N/A
- SLGL N/A
- EPS
- POCI N/A
- SLGL N/A
- Revenue
- POCI $17,626,155.00
- SLGL $12,103,000.00
- Revenue This Year
- POCI N/A
- SLGL N/A
- Revenue Next Year
- POCI N/A
- SLGL $31.17
- P/E Ratio
- POCI N/A
- SLGL N/A
- Revenue Growth
- POCI N/A
- SLGL 603.66
- 52 Week Low
- POCI $3.47
- SLGL $3.34
- 52 Week High
- POCI $6.59
- SLGL $16.50
- Technical
- Relative Strength Index (RSI)
- POCI 62.07
- SLGL 63.80
- Support Level
- POCI $4.62
- SLGL $6.96
- Resistance Level
- POCI $5.10
- SLGL $7.48
- Average True Range (ATR)
- POCI 0.32
- SLGL 0.28
- MACD
- POCI 0.02
- SLGL 0.07
- Stochastic Oscillator
- POCI 90.48
- SLGL 95.88
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.